Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial 2023-10-03 20:58
Caliway's CBL-514 Achieved Better Efficacy than Liposuction, Reducing over 300mL of Subcutaneous Fat on Average in CBL-0202 Study 2023-10-02 21:00
Flat Medical Secures Series C Funding Led by Taiwania Capital, Poised for Global Market Expansion 2023-10-02 20:30
Jin Medical International Limited Receives NASDAQ Notification Letter Regarding Noncompliance with Continued Listing Rule 5550(a)(3) 2023-09-29 04:30
SGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery 2023-09-28 21:30
ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023 2023-09-28 20:00
Mabwell Announces First Patient Dosed in Phase Ib/II Trial of its Novel Nectin-4 Targeting ADC in Combination with PD-1 Inhibitor 2023-09-28 20:00
IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023 2023-09-28 18:09
Akeso Announced FDA Clearance of IND for CD47 Monoclonal Antibody (AK117) in Combination with Azacitidine in Myelodysplastic Syndromes 2023-09-28 10:07
BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China 2023-09-28 09:46
OBiO has launched its state-of-the-art GMP production facility Intelli-M to expedite innovative and advanced therapies to patients who are in need. 2023-09-27 21:00
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference 2023-09-27 08:30
ABM Therapeutics' ABM-1310 Granted Fast Track Designation by the FDA Following Orphan Drug Designation 2023-09-27 00:00
China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering 2023-09-26 21:00
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update 2023-09-26 20:51
WuXi Vaccines Launches Its First Vaccines CDMO Site in China 2023-09-26 15:41
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology 2023-09-25 19:00
MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment 2023-09-23 18:29
FDA Grants Fast Track Designation to 9MW3011 2023-09-22 08:00
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function 2023-09-21 21:00
1 19 20 21 22 23 148